J Pediatr Genet 2022; 11(01): 015-021
DOI: 10.1055/s-0040-1717108
Original Article

Erythrocyte Complement Receptor 1 Gene Polymorphisms and Neonatal Respiratory Distress Syndrome

Walaa Rabie
1   Department of Clinical and Chemical Pathology, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt
,
Ahmed Al-Taweel
1   Department of Clinical and Chemical Pathology, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt
,
Walaa A. Abuelhamd
2   Department of Pediatrics, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt
,
Walaa Shahin
2   Department of Pediatrics, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt
,
Marian Nazeer
1   Department of Clinical and Chemical Pathology, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt
,
3   Department of Neonatology, Cleveland Clinic Children's, Cleveland, Ohio, United States
› Author Affiliations

Abstract

To evaluate the role of erythrocyte complement receptor 1 (ECR1) gene in the predisposition to respiratory distress syndrome (RDS), we studied 50 infants with RDS and 50 controls. Real-time polymerase chain reaction allelic discrimination analysis of A3650G (rs2274567) and genotyping of the alleles (HindIII) were performed. Allele L of HindIII restricted single nucleotide polymorphism (SNP) associated with the severity of RDS. Duration of oxygen and ventilation in genotypes AA and AG of A3650G SNP was longer than genotype GG (17.6 ± 19.4 and 8.6 ± 4.5 days, p = 0.01) and (8.9 ± 11.9 and 3.9 ± 3.53 days, p = 0.03), respectively. A3650G and HINDIII digested gene polymorphisms of ECR1 may be of little importance for RDS.



Publication History

Received: 28 May 2020

Accepted: 20 August 2020

Article published online:
05 October 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Hermansen CL, Lorah KN. Respiratory distress in the newborn. Am Fam Physician 2007; 76 (07) 987-994
  • 2 Hubbard RM, Choudhury KM, Lim G. Treatment patterns and clinical outcomes in neonates diagnosed with respiratory distress syndrome in a low-income country: a report from Bangladesh. Anesth Analg 2018; 126 (05) 1684-1686
  • 3 Heesterbeek DAC, Angelier ML, Harrison RA, Rooijakkers SHM. Complement and bacterial infections: from molecular mechanisms to therapeutic applications. J Innate Immun 2018; 10 (5-6): 455-464
  • 4 Anand D, Kumar U, Kanjilal M, Kaur S, Das N. Leucocyte complement receptor 1 (CR1/CD35) transcript and its correlation with the clinical disease activity in rheumatoid arthritis patients. Clin Exp Immunol 2014; 176 (03) 327-335
  • 5 Chiumello D, Cressoni M, Carlesso E. et al. Bedside selection of positive end-expiratory pressure in mild, moderate, and severe acute respiratory distress syndrome. Crit Care Med 2014; 42 (02) 252-264
  • 6 Dai Y, Wang QW, He S, Zhang Z, Gao C. Correlation of ECR1 A3650G polymorphism with neonatal respiratory distress syndrome. Genet Test Mol Biomarkers 2015; 19 (01) 18-23
  • 7 Xiang L, Rundles JR, Hamilton DR, Wilson JG. Quantitative alleles of CR1: coding sequence analysis and comparison of haplotypes in two ethnic groups. J Immunol 1999; 163 (09) 4939-4945
  • 8 Srivastava A, Mittal B. Complement receptor 1 (A3650G RsaI and intron 27 HindIII) polymorphisms and risk of gallbladder cancer in north Indian population. Scand J Immunol 2009; 70 (06) 614-620
  • 9 Tamano M, Ohi H, Sudo S, Tomino Y. Quantitative polymorphism of complement receptor type 1 (CR1) in patients undergoing haemodialysis. Nephrol Dial Transplant 2004; 19 (06) 1467-1473
  • 10 Wang FS, Chu FL, Jin L. et al. Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome. Clin Exp Immunol 2005; 139 (01) 112-119
  • 11 Hodgson U, Tukiainen P, Laitinen T. The polymorphism C5507G of complement receptor 1 does not explain idiopathic pulmonary fibrosis among the Finns. Respir Med 2005; 99 (03) 265-267
  • 12 Kubistova Z, Mrazek F, Lympany PA. et al. The CR1 C5507G polymorphism is not involved in susceptibility to idiopathic pulmonary fibrosis in two European populations. Tissue Antigens 2008; 72 (05) 483-486
  • 13 Sweet DG, Carnielli V, Greisen G. European Association of Perinatal Medicine. et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants–2013 update. Neonatology 2013; 103 (04) 353-368
  • 14 Paetzel M. Respiratory distress syndrome (grade 1–4) of the premature and newborn (IRDS). Ped Rad [serial online] vol 2, no. 11. Available at: www.PedRad.info/?search=20021110223558. Accessed June 25, 2020
  • 15 Hiles M, Culpan AM, Watts C, Munyombwe T, Wolstenhulme S. Neonatal respiratory distress syndrome: chest X-ray or lung ultrasound? A systematic review. Ultrasound 2017; 25 (02) 80-91
  • 16 Cornfield DN. Acute respiratory distress syndrome in children: physiology and management. Curr Opin Pediatr 2013; 25 (03) 338-343
  • 17 Im D, Shi W, Driscoll B. Pediatric acute respiratory distress syndrome: Fibrosis versus repair. Front Pediatr 2016; 4: 28
  • 18 Wen YH, Yang HI, Chou HC. Taiwan Premature Infant Developmental Collaborative Study Group. et al. Association of maternal preeclampsia with neonatal respiratory distress syndrome in very-low-birth-weight infants. Sci Rep 2019; 9 (01) 13212
  • 19 Shaikh N, Faizi S, Rai L. Respiratory morbidity in late-preterm births: a prospective observational study at a tertiary care hospital. J Obstet Gynaecol India 2016; 66 (Suppl. 01) 301-306
  • 20 Turitz AL, Gyamfi-Bannerman C. Comparison of respiratory outcomes between preterm smallfor-gestational-age and appropriate-for-gestational-age infants. Am J Perinatol 2017; 34 (03) 283-288